Published in Nephrol Dial Transplant on October 27, 2006
Treatment of chronic periodontitis decreases serum prohepcidin levels in patients with chronic kidney disease. Clinics (Sao Paulo) (2011) 1.50
Requirement of TLR4 and CD14 in dendritic cell activation by Hemagglutinin B from Porphyromonas gingivalis. Mol Immunol (2009) 0.99
TLR4 signaling via MyD88 and TRIF differentially shape the CD4+ T cell response to Porphyromonas gingivalis hemagglutinin B. J Immunol (2011) 0.95
Effect of chronic kidney disease on the healing of titanium implants. Bone (2013) 0.85
Vitamin D supplementation enhances the fixation of titanium implants in chronic kidney disease mice. PLoS One (2014) 0.85
Periodontal disease bacteria specific to tonsil in IgA nephropathy patients predicts the remission by the treatment. PLoS One (2014) 0.84
Is implanto-prosthodontic treatment available for haemodialysis patients? Nephrol Dial Transplant (2007) 0.81
Salivary Microbiota Associated with Immunoglobulin A Nephropathy. Microb Ecol (2015) 0.78
Comparison of oral Lactobacillus and Streptococcus mutans between diabetic dialysis patients with non-diabetic dialysis patients and healthy people. J Renal Inj Prev (2016) 0.77
Estimation of Specific Salivary Enzymatic Biomarkers in Individuals with Gingivitis and Chronic Periodontitis: A Clinical and Biochemical Study. J Int Oral Health (2015) 0.75
Medical and Periodontal Clinical Parameters in Patients at Different Levels of Chronic Renal Failure. Int J Dent (2017) 0.75
Evaluation of periodontal condition and risk in patients with chronic kidney disease on hemodialysis. Einstein (Sao Paulo) (2017) 0.75
The Phenotype and Function of Myeloid-derived Suppressor Cells Induced by Porphyromonas gingivalis Infection. Infect Immun (2017) 0.75
The periodontal status of pre-dialysis chronic kidney disease and maintenance dialysis patients. Nephrol Dial Transplant (2006) 2.62
In-center hemodialysis six times per week versus three times per week. N Engl J Med (2010) 10.73
Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med (2002) 10.52
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27
Effectiveness of a resin-modified glass ionomer liner in reducing hypersensitivity in posterior restorations: a study from the practitioners engaged in applied research and learning network. J Am Dent Assoc (2013) 3.18
Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRN. J Dent Res (2011) 3.01
Outcomes of endodontic therapy in general practice: a study by the Practitioners Engaged in Applied Research and Learning Network. J Am Dent Assoc (2012) 2.90
Body fluid volume determination via body composition spectroscopy in health and disease. Physiol Meas (2006) 2.84
Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Intern Med (2005) 2.82
Statin use and sepsis events [corrected] in patients with chronic kidney disease. JAMA (2007) 2.69
Hospitalization and mortality in hemodialysis patients: association with hemoglobin variability. Blood Purif (2013) 2.56
Relationships among inflammation nutrition and physiologic mechanisms establishing albumin levels in hemodialysis patients. Kidney Int (2002) 2.27
The epidemiology of systolic blood pressure and death risk in hemodialysis patients. Am J Kidney Dis (2006) 2.22
Periodontal diagnosis affected by variation in terminology. J Periodontol (2012) 2.13
Effect of frequent hemodialysis on residual kidney function. Kidney Int (2013) 2.10
Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol (2005) 2.07
Peginesatide in patients with anemia undergoing hemodialysis. N Engl J Med (2013) 2.00
Frequency of patient-physician contact and patient outcomes in hemodialysis care. J Am Soc Nephrol (2004) 1.97
Relationship between volume status and blood pressure during chronic hemodialysis. Kidney Int (2002) 1.93
Mortality among hemodialysis patients in Europe, Japan, and the United States: case-mix effects. Am J Kidney Dis (2004) 1.84
Inflammation and Alzheimer's disease: possible role of periodontal diseases. Alzheimers Dement (2007) 1.82
Periodontal disease adversely affects the survival of patients with end-stage renal disease. Kidney Int (2009) 1.74
Membrane targeting and secretion of mutant uromodulin in familial juvenile hyperuricemic nephropathy. J Am Soc Nephrol (2006) 1.73
Treatment of deep carious lesions by complete excavation or partial removal: a critical review. J Am Dent Assoc (2008) 1.71
Serum potassium and outcomes in CKD: insights from the RRI-CKD cohort study. Clin J Am Soc Nephrol (2010) 1.69
The KDIGO guideline for dialysate calcium will result in an increased incidence of calcium accumulation in hemodialysis patients. Kidney Int (2010) 1.61
Interdialytic weight gain, systolic blood pressure, serum albumin, and C-reactive protein levels change in chronic dialysis patients prior to death. Kidney Int (2013) 1.56
Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study. J Am Soc Nephrol (2003) 1.56
Association between markers of collagen turnover, arterial stiffness and left ventricular hypertrophy in chronic kidney disease (CKD): the Renal Research Institute (RRI)-CKD study. Nephrol Dial Transplant (2011) 1.50
International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality. J Am Soc Nephrol (2006) 1.49
Dynamics of hospitalizations in hemodialysis patients: results from a large US provider. Nephrol Dial Transplant (2013) 1.49
Standard Kt/Vurea: a method of calculation that includes effects of fluid removal and residual kidney clearance. Kidney Int (2010) 1.43
Can technology solve the clinical problem of 'dry weight'? Nephrol Dial Transplant (2003) 1.42
Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patients. Kidney Int (2004) 1.40
Noninvasive transcutaneous access flow measurement before and after hemodialysis: impact of hematocrit and blood pressure. Blood Purif (2002) 1.39
The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant (2008) 1.39
Uromodulin mutations causing familial juvenile hyperuricaemic nephropathy lead to protein maturation defects and retention in the endoplasmic reticulum. Hum Mol Genet (2009) 1.24
Comparison of outcomes on continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis: results from a USA database. Perit Dial Int (2010) 1.23
Baseline characteristics of participants in the Frequent Hemodialysis Network (FHN) daily and nocturnal trials. Am J Kidney Dis (2010) 1.19
Predictors of heart rate variability and its prognostic significance in chronic kidney disease. Nephrol Dial Transplant (2011) 1.18
Blood pressure in chronic kidney disease stage 5D-report from a Kidney Disease: Improving Global Outcomes controversies conference. Kidney Int (2009) 1.16
Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials. Circ Cardiovasc Imaging (2012) 1.16
Practice-based research networks and their impact on dentistry: creating a pathway for change in the profession. Compend Contin Educ Dent (2009) 1.15
Significance of interdialytic weight gain versus chronic volume overload: consensus opinion. Am J Nephrol (2013) 1.14
Mortality predictability of body size and muscle mass surrogates in Asian vs white and African American hemodialysis patients. Mayo Clin Proc (2013) 1.14
Evidence for a role of uromodulin in chronic kidney disease progression. Nephrol Dial Transplant (2010) 1.14
Incidence of end-stage renal disease and death among insured African Americans with chronic kidney disease. Kidney Int (2009) 1.13
Early, intermediate, and long-term risk factors for mortality in incident dialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. Am J Kidney Dis (2007) 1.12
Bioimpedance, dry weight and blood pressure control: new methods and consequences. Curr Opin Nephrol Hypertens (2005) 1.11
Postoperative hypersensitivity in class I resin-based composite restorations in general practice: interim results. Compend Contin Educ Dent (2009) 1.09
Alzheimer's disease and peripheral infections: the possible contribution from periodontal infections, model and hypothesis. J Alzheimers Dis (2008) 1.08
Frequency of patient-physician contact in chronic kidney disease care and achievement of clinical performance targets. Int J Qual Health Care (2005) 1.08
Attainment of clinical performance targets and improvement in clinical outcomes and resource use in hemodialysis care: a prospective cohort study. BMC Health Serv Res (2007) 1.08
Estimation of total-body and limb muscle mass in hemodialysis patients by using multifrequency bioimpedance spectroscopy. Am J Clin Nutr (2005) 1.07
Association between serum 2-microglobulin level and infectious mortality in hemodialysis patients. Clin J Am Soc Nephrol (2007) 1.07
Racial differences in estimated GFR decline, ESRD, and mortality in an integrated health system. Am J Kidney Dis (2013) 1.06
TNF-alpha and antibodies to periodontal bacteria discriminate between Alzheimer's disease patients and normal subjects. J Neuroimmunol (2009) 1.05
Longitudinal and cross-sectional effects of C-reactive protein, equilibrated normalized protein catabolic rate, and serum bicarbonate on creatinine and albumin levels in dialysis patients. Am J Kidney Dis (2003) 1.05
Extracorporeal therapies in non-renal disease: treatment of sepsis and the peak concentration hypothesis. Blood Purif (2004) 1.05
Peritoneal dialysis for acute kidney injury in sub-Saharan Africa: challenges faced and lessons learned at Kilimanjaro Christian Medical Centre. Kidney Int (2012) 1.02
Predicting risk for bisphosphonate-related osteonecrosis of the jaws: CTX versus radiographic markers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2010) 1.02
Uric acid levels and all-cause and cardiovascular mortality in the hemodialysis population. Clin J Am Soc Nephrol (2011) 1.01
Dentin caries activity in early occlusal lesions selected to receive operative treatment: findings from the Practitioners Engaged in Applied Research and Learning (PEARL) Network. J Am Dent Assoc (2012) 1.01
Intestinal bacterial microflora--a potential source of chronic inflammation in patients with chronic kidney disease. Nephrol Dial Transplant (2006) 1.01
Intradialytic hypotension: frequency, sources of variation and correlation with clinical outcome. Hemodial Int (2014) 1.01
Comparison of proposed alternative methods for rescaling dialysis dose: resting energy expenditure, high metabolic rate organ mass, liver size, and body surface area. Semin Dial (2008) 1.00
Control of core temperature and blood pressure stability during hemodialysis. Clin J Am Soc Nephrol (2008) 0.99
Challenges to enrollment and randomization of the Frequent Hemodialysis Network (FHN) Daily Trial. J Nephrol (2012) 0.99
Hemoglobin and plasma vitamin C levels in patients on peritoneal dialysis. Perit Dial Int (2010) 0.99
Red blood cell lifespan, erythropoiesis and hemoglobin control. Contrib Nephrol (2008) 0.99
Effects of frequent hemodialysis on ventricular volumes and left ventricular remodeling. Clin J Am Soc Nephrol (2013) 0.98
Current state of bioimpedance technologies in dialysis. Nephrol Dial Transplant (2008) 0.97
Iron and anemia in human biology: a review of mechanisms. Heart Fail Rev (2008) 0.96
Prevalence of chronic kidney disease in patients with suspected sleep apnoea. Nephrol Dial Transplant (2009) 0.96
C-reactive protein and end-stage renal disease. Semin Dial (2005) 0.95
Serum markers of periodontal disease status and inflammation in hemodialysis patients. Am J Kidney Dis (2002) 0.95
The MONitoring Dialysis Outcomes (MONDO) initiative. Blood Purif (2013) 0.95
Effects of citrate acid concentrate (citrasate®) on heparin N requirements and hemodialysis adequacy: a multicenter, prospective noninferiority trial. Blood Purif (2012) 0.95
Dominance of traditional cardiovascular risk factors over renal function in predicting arterial stiffness in subjects with chronic kidney disease. Nephrol Dial Transplant (2009) 0.94